Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1024666.RAHAHYTZJZrFHW6l52KG6vXTY5Spgyg3bOz01GrLud_oo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1024666.RAHAHYTZJZrFHW6l52KG6vXTY5Spgyg3bOz01GrLud_oo130_assertion type Assertion NP1024666.RAHAHYTZJZrFHW6l52KG6vXTY5Spgyg3bOz01GrLud_oo130_head.
- NP1024666.RAHAHYTZJZrFHW6l52KG6vXTY5Spgyg3bOz01GrLud_oo130_assertion description "[In contrast, SOCE agonists should attenuate mTOR inhibitors-mediated AKT reactivation and consequently potentiate their efficacy in the treatment of the patients with TSC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024666.RAHAHYTZJZrFHW6l52KG6vXTY5Spgyg3bOz01GrLud_oo130_provenance.
- NP1024666.RAHAHYTZJZrFHW6l52KG6vXTY5Spgyg3bOz01GrLud_oo130_assertion evidence source_evidence_literature NP1024666.RAHAHYTZJZrFHW6l52KG6vXTY5Spgyg3bOz01GrLud_oo130_provenance.
- NP1024666.RAHAHYTZJZrFHW6l52KG6vXTY5Spgyg3bOz01GrLud_oo130_assertion SIO_000772 23108404 NP1024666.RAHAHYTZJZrFHW6l52KG6vXTY5Spgyg3bOz01GrLud_oo130_provenance.
- NP1024666.RAHAHYTZJZrFHW6l52KG6vXTY5Spgyg3bOz01GrLud_oo130_assertion wasDerivedFrom befree-2016 NP1024666.RAHAHYTZJZrFHW6l52KG6vXTY5Spgyg3bOz01GrLud_oo130_provenance.
- NP1024666.RAHAHYTZJZrFHW6l52KG6vXTY5Spgyg3bOz01GrLud_oo130_assertion wasGeneratedBy ECO_0000203 NP1024666.RAHAHYTZJZrFHW6l52KG6vXTY5Spgyg3bOz01GrLud_oo130_provenance.